Back
iShares Core MSCI Emerging Markets ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
65
IEMG
iShares Core MSCI Emerging Markets ETF
Last Price:
$67.24
Seasonality Move:
0.24%
Sell
39
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.25
Seasonality Move:
-0.81%
Buy
65
iShares Core MSCI Emerging Markets ETF (IEMG)
is a Buy
Is iShares Core MSCI Emerging Markets ETF a Buy, Sell or Hold?
-
The current iShares Core MSCI Emerging Markets ETF [IEMG] share price is $67.22. The Score for IEMG is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
IEMG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $36.31. The Score for ZBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IEMG Stock Price Chart
What is iShares Core MSCI Emerging Markets ETF's stock price today?
-
The iShares Core MSCI Emerging Markets ETF share price today is $67.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IEMG is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $36.31The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
IEMG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 53.72 | Buy |
| Chaikin Money Flow: | -12818452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.05 - 67.57) | Buy |
| Bollinger Bands (100): | (63.58 - 67.92) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.68 | Buy |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | 289999 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.8 - 41.14) | Sell |
| Bollinger Bands (100): | (19.01 - 36.29) | Buy |
IEMG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.76 | Buy |
| 20-day SMA: | 66.82 | Buy |
| 50-day SMA: | 67.26 | Sell |
| 200-day SMA: | 61.37 | Buy |
| 8-day EMA: | 66.94 | Buy |
| 20-day EMA: | 66.83 | Buy |
| 50-day EMA: | 65.83 | Buy |
| 200-day EMA: | 43.33 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.86 | Sell |
| 20-day SMA: | 38.54 | Sell |
| 50-day SMA: | 35.24 | Buy |
| 200-day SMA: | 19.17 | Buy |
| 8-day EMA: | 35.64 | Buy |
| 20-day EMA: | 24.68 | Buy |
| 50-day EMA: | 12.87 | Buy |
| 200-day EMA: | 3.71 | Buy |
iShares Core MSCI Emerging Markets ETF Earnings Growth & IEMG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.15 per share.
iShares Core MSCI Emerging Markets ETF Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||